Archive: 04/11/2013

J&J to pay $2.2B to settle marketing allegations (Update)

Johnson & Johnson and its subsidiaries have agreed to pay over $2.2 billion to resolve criminal and civil allegations that the company promoted powerful psychiatric drugs for unapproved uses in children, seniors and disabled ...

page 4 from 9